Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Am J Infect Control ; 49(9): 1204-1205, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-33974933

RESUMO

Our study surveyed over 2000 employees of a community health care system in the Southeast United States for SARS-CoV2 antibodies. Survey included subjects' expectation of the result. Our local area had low community prevalence of SARS-CoV2 but low diagnostic testing capacity during much of the early phase of the epidemic. Despite only 3% positivity rate for antibodies in this population, 17% of subjects expected to have positive antibodies.


Assuntos
Anticorpos Antivirais/sangue , COVID-19 , Pessoal de Saúde , COVID-19/diagnóstico , COVID-19/imunologia , Teste Sorológico para COVID-19 , Hospitais Comunitários , Humanos , North Carolina/epidemiologia , Estudos Soroepidemiológicos
2.
Am J Infect Control ; 47(8): 1028-1029, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-30665779

RESUMO

This study was a retrospective chart review from January 1, 2015 through June 30, 2017, comparing the incidence of Clostridium difficile-associated diarrhea (CDAD) in patients taking select broad spectrum antibiotics with probiotics versus without probiotics. The purpose was to determine if probiotic use was associated with a reduction in the incidence of CDAD. A total of 5,574 hospital encounters were reviewed, showing a 0.96% incidence of CDAD in patients receiving a probiotic compared to a 2.19% incidence of CDAD in patients with no probiotic (risk ratio = 0.442; P = .00743). These findings show probiotic use was associated with a statistically significant lower incidence of positive C. difficile test results compared to no probiotic use.


Assuntos
Clostridioides difficile , Diarreia/prevenção & controle , Enterocolite Pseudomembranosa/microbiologia , Enterocolite Pseudomembranosa/prevenção & controle , Probióticos/farmacologia , Antibacterianos/efeitos adversos , Enterocolite Pseudomembranosa/etiologia , Humanos , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA